New asthma inhaler propellant tested for safety in completed study
NCT ID NCT05850494
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a new propellant (HFO) in asthma inhalers causes airway narrowing (bronchospasm) compared to the standard propellant (HFA). It involved 52 adults with well-controlled or partially controlled asthma. Researchers measured lung function right after use and checked for any breathing problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
North Dartmouth, Massachusetts, 02747, United States
-
Research Site
St Louis, Missouri, 63141, United States
-
Research Site
Raleigh, North Carolina, 27607, United States
-
Research Site
El Paso, Texas, 79903, United States